Innovation and excellence in science and health

Occupiers

The main organisations located on the Campus are Cambridge University Hospitals NHS Foundation Trust, the University of Cambridge School of Clinical Medicine, the Medical Research Council Laboratory of Molecular Biology and GlaxoSmithKline. AstraZeneca’s new global R&D Centre and Corporate HQ and the new Papworth Hospital are due to open in 2018. Other biomedical and biomedical-related companies are encouraged to locate on the Campus as part of the commercial expansion that is now underway.

HOSPITALS
Currently on campus
Cambridge University Hospitals NHS Foundation TrustAddenbrooke’s Hospital (the teaching hospital of the University of Cambridge) and the Rosie Hospital (maternity hospital for the Cambridge sub-region)
Cambridgeshire and Peterborough NHS Foundation Trust (CPFT)Designated Cambridge University Teaching Trust providing mental health services to the 755,000 residents of Cambridgeshire and Peterborough (some functions only on the Campus- main site located at Fulbourn)
Relocations
Papworth Hospital NHS Foundation TrustThe largest specialist cardiothoracic hospital in the UK (due to relocate to the Campus in 2018)

MAIN RESEARCH-FOCUSED ORGANISATIONS
School of Clinical Medicine – University of Cambridge
The Clinical School of the University of Cambridge encompassing 4 research institutes and 14 clinically-focused departments.
MRC Institute
MRC Laboratory of Molecular Biology
- associated with 10 Nobel Prizes shared by 14 scientists

MRC Units
MRC Mitochondrial Biology Unit
- investigates the fundamental processes taking place in mitochrondria and the involvement of these processes in human disease
MRC Metabolic Diseases Unit (MDU)
- wide-ranging research into the causes, prevention and treatment of obesity and related diseases
MRC Cancer Unit
- research into the control of cell growth, proliferation and genome stability, and how these processes differ in normal and cancerous cells
MRC Epidemiology Unit
- investigation of the causes and prevention of diabetes and obesity
MRC Biostatistics Unit
- centre of excellence on statistical methods and their application to epidemiology and biomedical studies

COMMERCIAL & OTHER OCCUPIERS
AstraZenecaIn June 2013, AZ announced that it was moving its corporate HQ and establishing a global R&D centre at the campus.
GlaxoSmithKline Clinical Unit CambridgeClinical trial unit embedded within Addenbrooke's Hospital involved in Phase 1 and early Phase 2 studies
NHS Blood and TransplantA special Health Authority in the NHS with responsibility for optimising the supply of blood, organs, and tissues and raising the quality, effectiveness and efficiency of blood and transplant services
The Deakin Learning Centre A social learning environment designed to provide a range of high quality community services combined with excellent education and training provision
Cambridge University Health PartnersOne of only five Academic Health Science Centres in England recognised by the Department of Health as internationally competitive centres of excellence in the integrated delivery of health care, health research and the education of health professionals.
Eastern Academic Health Science NetworkOne of 15 health networks (AHSNs) set up to spread innovation at pace and scale across the healthcare system – in order to achieve the ultimate goals of both improving health and generating economic growth
The Milner Therapeutics Institute and ConsortiumDedicated to the conversion of basic science into therapies; connects academic scientists and institutions in Cambridge with the pharmaceutical industry, to develop the therapeutic potential of their research;
ideaSpace SouthA coworking area designed for people/companies with scalable, innovative ideas which could potentially have a global impact.

VIRTUAL ORGANISATIONS
NIHR Cambridge Biomedical Research CentreNIHR funded partnership between Cambridge University Hospitals Foundation Trust and the University of Cambridge
Cambridge Cancer CentreBrings together researchers from Cambridge and surrounding areas (from the University, Institutes, Addenbrooke's and biotech) whose work has current or potential application to cancer research. The goal is to promote collaborative projects at the interface between different disciplines.